NURAFIVA

This brand name is authorized in Nigeria.

Active ingredients

The drug NURAFIVA contains one active pharmaceutical ingredient (API):

1
UNII 362O9ITL9D - ACETAMINOPHEN
 

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.

 
Read more about Paracetamol

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100903 Injection Nurafiva Injection 150 mg_ INJ 150 mg/mL 10 x 2 mL (in amber blue dot OPC glass ampoule) A clear colourless oily solution. 63 NF-PP-382859 NURAFIVA INJECTION 150MG PARACETAMOL BP 150MG/ML PARACETAMOL BP 150MG/ML, BENZYL ALCOHOL BP 2%V/V, WATER FOR INJECTION BP QS A4-100903 Drugs Imported Products 2ML10 POM 1 11/1/2023 AL-SAMPARDA PHARMACEUTICALS NIGERIA LIMITED, NO 24, ABUJA ROAD SABO-TASHA KADUNA SOUTH KADUNA 8038540440 alsampardapharm@outlook.com FARBE FIRMA PRIVATE LIMITED, Plot No, 1508, GIDC, ANKLESHWAR 393002, GUJARAT, India 27/06/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N02BE01 Paracetamol N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides
Discover more medicines within N02BE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100903

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.